Enjoy complimentary customisation on priority with our Enterprise License!
The Immunohistochemistry (IHC) Market size is estimated to grow by USD 1,067.13 million at a CAGR of 7.52% between 2022 and 2027.
There has been a growing demand for immunohistochemistry due to the increase in the number of ancient patients across the world. the rise in the number of cancer patients globally is a major healthcare challenge with significant implications for healthcare systems, research, and public health initiatives. As per the WHO, over 19 million new cancer cases were estimated worldwide in 2020, causing around 9.9 million deaths across the world. As a result of this increasing prevalence of cancer, there is a growing research effort to develop new treatments and understand disease mechanisms. Therefore, it fuels the demand for immunohistochemistry which is an essential tool for studying the expression and localization of proteins in cancer tissue, aiding in drug discovery and development. Hence, such factors are positively impacting the market.
Technavio has segmented the market into Application, End-user, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The diagnostic application segment is estimated to witness significant growth during the forecast period. There is an increasing adoption of immunohistochemistry across several areas of diagnostics, especially in pathology and molecular biology. this mainly comprises the localization and visualization of specific proteins or antigens in tissue sections using antibodies that bind to those antigens. This technique plays a major role in understanding disease processes, recognizing biomarkers, and aiding in patient diagnosis and treatment.
Get a glance at the market contribution of various segments View a PDF Sample
The diagnostic application segment was the largest segment and was valued at USD 1,171.39 million in 2017. The main purpose of immunohistochemistry is that it enables the identification of specific protein markers associated with various diseases, such as cancer. Such techniques help to tailor a treatment plan as per the needs of individual patients resulting in more effective and targeted therapies. These biomarkers are extensively used for early detection, prognosis, and predicting treatment response. The increasing demand for immunohistochemistry in diagnostics is fuelled by its role in advancing personalized medicine, enhancing disease understanding, and supporting the development of targeted therapies. Hence, such factors are expected to fuel the growth of this segment which, in turn, will drive the market growth during the forecast period.
Several factors related to patient care, disease diagnosis, and treatment planning are influencing the demand for immunohistochemistry tests in hospitals. Immunohistochemistry plays a major role in the diagnosis and staging of different types of cancers, including bladder cancer, breast cancer, and colorectal cancer. This technique enables pathologists to identify specific protein markers that show the origin and characteristics of tumors. It is essential information for determining the appropriate treatment strategy and prognosis. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The increasing demand for immunohistochemistry tests in North America is influenced by several factors including the advanced healthcare system, research capabilities, and commitment to precision medicine in the region. Several countries in North America such as the US and Canada have well-developed infrastructure with many hospitals, research institutes, and clinics which is positively impacting the market growth in the region.
Additionally, the presence of reputed universities, research centers, and pharmaceutical companies are often at the forefront of developing new diagnostic techniques and therapies significantly contributing to the market growth in the region. There is an increasing focus by the region on precision medicine, its robust healthcare and research infrastructure, and its leadership in medical innovation which is fuelling the demand for immunohistochemistry tests in the region. Hence, such factors are expected to drive the market growth in the region during the forecast period.
In 2020, during the COVID-19 pandemic, the growth of the global immunohistochemistry market witnessed a significant slowdown as healthcare resources were managing and treating COVID-19 cases, and non-urgent medical procedures, including some diagnostic tests, were postponed or limited in North America. However, in 2021, the initiation of large-scale vaccination drives lifted the lockdown and travel restrictions, which led to the restoration of operations in healthcare units as well as the resumption of research. Such factors are expected to drive the market during the forecast period
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Agilent Technologies Inc: The company offers immunohistochemistry solutions for pathology laboratories to achieve high staining quality, improved standardization and increased efficiency, enabling the ultimate goal of increased patient safety.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
A key factor shaping the immunohistochemistry market growth is the automation and digitalization of immunohistochemistry processes. There is an increasing prevalence of automation in immunohistochemistry processes, along with the integration of digital imaging and pathology. The emergence of automated immunohistochemistry platforms and digital pathology solutions is improving efficiency, minimizing variability, and enabling remote analysis and collaboration.
Moreover, the main advantage of automating the process is that it reduces human variability, leading to consistent and reproducible staining results across various slides and experiments. Additionally, there is an increasing adoption of immunohistochemistry automation fuelled by the need for standardized and reliable results, higher efficiency, and improved laboratory workflow. Hence, such factors are positively impacting the immunohistochemistry (IHC) market growth. Therefore, it is expected to drive the market growth during the forecast period.
High costs associated with immunohistochemistry are one of the key challenges hindering the immunohistochemistry market growth. Some of the key costs in immunohistochemistry include different aspects of the process, from reagents and equipment to labor and quality control. Additionally, there is a significant requirement for High-quality antibodies and reagents for obtaining accurate and reliable results in immunohistochemistry.
Moreover, it is essential for antibodies to be sourced from specialized suppliers, and the cost of antibodies can depend on specificity, validation, and availability. Additionally, several automated platforms and equipment utilized for immunohistochemistry can have huge upfront costs. Even though automation enhances efficiency and accuracy, the substantial investment required is a significant cost factor. Hence, such factors are expected to negatively impact the immunohistochemical (IHC) market. Therefore, it is expected to hinder the market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Immunohistochemistry Market Customer Landscape
The immunohistochemistry market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
|
Immunohistochemistry Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
151 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.52% |
|
Market growth 2023-2027 |
USD 1,067.13 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
7.32 |
|
Regional analysis |
North America, Europe, APAC, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key countries |
US, China, Germany, France, and UK |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio SB, Bio Techne Corp., Biocare Medical LLC, BioGenex Laboratories Inc., CANDOR Bioscience GmbH, Cell Signaling Technology Inc., Danaher Corp., Eagle Biosciences Inc., Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PerkinElmer Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., PHC Holdings Corp., and SAKURA SEIKI Co. Ltd. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Get the report (PDF) sent to your email within minutes.
